Company Filing History:
2 out of 3 
2 out of 3 Years Active: 2018-2020
Title: Innovations of Xiaoling Zeng in Osteoarthritis Treatment
Introduction
Xiaoling Zeng is a prominent inventor based in Shanghai, China. She has made significant contributions to the field of biomedical research, particularly in the treatment of osteoarthritis. With a total of 2 patents, her work focuses on the use of innovative cellular therapies.
Latest Patents
Zeng's latest patents include the use of allogeneic interstitial vessel-layer cells and allogeneic mesenchymal progenitor cells for preventing or treating osteoarthritis. These patents detail the preparation of a pharmaceutical composition that utilizes these cells to address the challenges associated with osteoarthritis (OA). The compositions are designed to enhance the therapeutic potential of these allogeneic cells in clinical applications.
Career Highlights
Throughout her career, Xiaoling Zeng has worked with notable organizations, including Cellular Biomedicine Group (Shanghai) Ltd. and Cellular Biomedicine Group (Wuxi) Ltd. Her experience in these companies has allowed her to advance her research and contribute to the development of innovative treatments.
Collaborations
Zeng has collaborated with esteemed colleagues such as Wei Cao and Mohammad Abdul Kaium. These partnerships have fostered a collaborative environment that enhances the research and development of her innovative solutions.
Conclusion
Xiaoling Zeng's contributions to the field of osteoarthritis treatment through her innovative patents and collaborations highlight her role as a leading inventor in biomedical research. Her work continues to pave the way for advancements in therapeutic strategies for osteoarthritis.